Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

[Review on anti-glomerular basement membrane disease or Goodpasture's syndrome].

Marques C, Plaisier E, Cacoub P, Cadranel J, Saadoun D.

Rev Med Interne. 2020 Jan;41(1):14-20. doi: 10.1016/j.revmed.2019.10.338. Epub 2019 Nov 24. French.

PMID:
31776042
2.

Prognostic Factors in Anti-glomerular Basement Membrane Disease: A Multicenter Study of 119 Patients.

Marques C, Carvelli J, Biard L, Faguer S, Provôt F, Matignon M, Boffa JJ, Plaisier E, Hertig A, Touzot M, Moranne O, Belenfant X, Annane D, Quéméneur T, Cadranel J, Izzedine H, Bréchot N, Cacoub P, Piedrafita A, Jourde-Chiche N, Saadoun D.

Front Immunol. 2019 Jul 18;10:1665. doi: 10.3389/fimmu.2019.01665. eCollection 2019.

3.

Efficacy of Rituximab in a Patient With Partial Clinical Remission and Persistent Circulating PLA2R-Ab.

Georges E, Johanet C, Plaisier E, Debiec H, Ronco P, Dahan K.

Kidney Int Rep. 2019 Mar 13;4(7):1027-1030. doi: 10.1016/j.ekir.2019.03.002. eCollection 2019 Jul. No abstract available.

4.

Prevalence of tubulopathy and association with renal function loss in HIV-infected patients.

Lescure FX, Fellahi S, Pialoux G, Bastard JP, Eme AL, Esteve E, Lebrette MG, Guiard-Schmid JB, Capeau J, Ronco P, Costagliola D, Plaisier E.

Nephrol Dial Transplant. 2019 May 9. pii: gfz081. doi: 10.1093/ndt/gfz081. [Epub ahead of print]

PMID:
31071216
5.

Aside from acute renal failure cases, are urinary markers of glomerular and tubular function useful in clinical practice?

Bastard JP, Fellahi S, Regeniter A, Capeau J, Ronco P, Plaisier E.

Clin Biochem. 2019 Mar;65:1-6. doi: 10.1016/j.clinbiochem.2019.01.006. Epub 2019 Jan 25. Review.

PMID:
30685208
6.

Retreatment with rituximab for membranous nephropathy with persistently elevated titers of anti-phospholipase A2 receptor antibody.

Dahan K, Johannet C, Esteve E, Plaisier E, Debiec H, Ronco P.

Kidney Int. 2019 Jan;95(1):233-234. doi: 10.1016/j.kint.2018.08.045. No abstract available.

PMID:
30606419
7.

Minimal change nephrotic syndrome in patients infected with human immunodeficiency virus: a retrospective study of 8 cases.

Arrestier R, Satie AP, Zhang SY, Plaisier E, Isnard-Bagnis C, Gatault P, Raimbourg Q, Buob D, Vocila F, Heng AE, Francois H, Moktefi A, Canaud G, Matignon M, Dejucq-Rainsford N, Brocheriou I, Sahali D, Audard V.

BMC Nephrol. 2018 Nov 20;19(1):331. doi: 10.1186/s12882-018-1132-x.

8.

Apolipoprotein CII Amyloidosis Associated With p.Lys41Thr Mutation.

Sethi S, Dasari S, Plaisier E, Ronco P, Nasr SH, Brocheriou I, Theis JD, Vrana JA, Zimmermann MT, Quint PS, McPhail ED, Kurtin PJ.

Kidney Int Rep. 2018 Apr 22;3(5):1193-1201. doi: 10.1016/j.ekir.2018.04.009. eCollection 2018 Sep.

9.

Decreased expression of megalin and cubilin and altered mitochondrial activity in tenofovir nephrotoxicity.

Cez A, Brocheriou I, Lescure FX, Adam C, Girard PM, Pialoux G, Moestrup SK, Fellahi S, Bastard JP, Ronco P, Plaisier E.

Hum Pathol. 2018 Mar;73:89-101. doi: 10.1016/j.humpath.2017.12.018. Epub 2018 Jan 5.

PMID:
29309806
10.

Severity of arterial defects in the retina correlates with the burden of intracerebral haemorrhage in COL4A1-related stroke.

Ratelade J, Mezouar N, Domenga-Denier V, Rochey A, Plaisier E, Joutel A.

J Pathol. 2018 Apr;244(4):408-420. doi: 10.1002/path.5023. Epub 2018 Feb 14.

PMID:
29266233
11.

Interest of the combined measurement of selected urinary proteins in the diagnosis approach in nephrology.

Bastard JP, Fellahi S, Lescure FX, Capeau J, Ronco P, Plaisier E.

Ann Biol Clin (Paris). 2017 Jun 1;75(3):327-333. doi: 10.1684/abc.2017.1247.

PMID:
28540855
12.

Multiplex and accurate quantification of acute kidney injury biomarker candidates in urine using Protein Standard Absolute Quantification (PSAQ) and targeted proteomics.

Gilquin B, Louwagie M, Jaquinod M, Cez A, Picard G, El Kholy L, Surin B, Garin J, Ferro M, Kofman T, Barau C, Plaisier E, Ronco P, Brun V.

Talanta. 2017 Mar 1;164:77-84. doi: 10.1016/j.talanta.2016.11.023. Epub 2016 Nov 13.

PMID:
28107998
13.

Col4a1 mutation generates vascular abnormalities correlated with neuronal damage in a mouse model of HANAC syndrome.

Trouillet A, Lorach H, Dubus E, El Mathari B, Ivkovic I, Dégardin J, Simonutti M, Paques M, Guillonneau X, Sennlaub F, Sahel JA, Ronco P, Plaisier E, Picaud S.

Neurobiol Dis. 2017 Apr;100:52-61. doi: 10.1016/j.nbd.2016.12.014. Epub 2017 Jan 3.

PMID:
28057519
14.

HANAC Col4a1 Mutation in Mice Leads to Skeletal Muscle Alterations due to a Primary Vascular Defect.

Guiraud S, Migeon T, Ferry A, Chen Z, Ouchelouche S, Verpont MC, Sado Y, Allamand V, Ronco P, Plaisier E.

Am J Pathol. 2017 Mar;187(3):505-516. doi: 10.1016/j.ajpath.2016.10.020. Epub 2017 Jan 3.

15.

Systemic vasculitis associated with vemurafenib treatment: Case report and literature review.

Mirouse A, Savey L, Domont F, Comarmond C, Barete S, Plaisier E, Rouvier P, Cacoub P, Saadoun D.

Medicine (Baltimore). 2016 Nov;95(46):e4988. Review.

16.

Renal outcomes after up to 8 years of tenofovir exposure in HIV-HBV-coinfected patients.

Boyd A, Miailhes P, Lascoux-Combe C, Rougier H, Girard PM, Plaisier E, Lacombe K.

Antivir Ther. 2017;22(1):31-42. doi: 10.3851/IMP3076. Epub 2016 Aug 24.

PMID:
27553871
17.

COL4A1-Related Disorders.

Plaisier E, Ronco P.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2020.
2009 Jun 25 [updated 2016 Jul 7].

18.

Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up.

Dahan K, Debiec H, Plaisier E, Cachanado M, Rousseau A, Wakselman L, Michel PA, Mihout F, Dussol B, Matignon M, Mousson C, Simon T, Ronco P; GEMRITUX Study Group.

J Am Soc Nephrol. 2017 Jan;28(1):348-358. doi: 10.1681/ASN.2016040449. Epub 2016 Jun 27.

19.

Non HCV-related infectious cryoglobulinemia vasculitis: Results from the French nationwide CryoVas survey and systematic review of the literature.

Terrier B, Marie I, Lacraz A, Belenotti P, Bonnet F, Chiche L, Graffin B, Hot A, Kahn JE, Michel C, Quemeneur T, de Saint-Martin L, Hermine O, Léger JM, Mariette X, Senet P, Plaisier E, Cacoub P.

J Autoimmun. 2015 Dec;65:74-81. doi: 10.1016/j.jaut.2015.08.008. Epub 2015 Aug 29. Review.

PMID:
26320984
20.

Spectrum and Prognosis of Noninfectious Renal Mixed Cryoglobulinemic GN.

Zaidan M, Terrier B, Pozdzik A, Frouget T, Rioux-Leclercq N, Combe C, Lepreux S, Hummel A, Noël LH, Marie I, Legallicier B, François A, Huart A, Launay D, Kaplanski G, Bridoux F, Vanhille P, Makdassi R, Augusto JF, Rouvier P, Karras A, Jouanneau C, Verpont MC, Callard P, Carrat F, Hermine O, Léger JM, Mariette X, Senet P, Saadoun D, Ronco P, Brochériou I, Cacoub P, Plaisier E; CryoVas study group.

J Am Soc Nephrol. 2016 Apr;27(4):1213-24. doi: 10.1681/ASN.2015020114. Epub 2015 Aug 10.

21.

HANAC Syndrome Col4a1 Mutation Causes Neonate Glomerular Hyperpermeability and Adult Glomerulocystic Kidney Disease.

Chen Z, Migeon T, Verpont MC, Zaidan M, Sado Y, Kerjaschki D, Ronco P, Plaisier E.

J Am Soc Nephrol. 2016 Apr;27(4):1042-54. doi: 10.1681/ASN.2014121217. Epub 2015 Aug 10.

22.

Bilateral kidney infarction due to primary Al amyloidosis: a first case report.

Mihout F, Joseph L, Brocheriou I, Leblond V, Varnous S, Ronco P, Plaisier E.

Medicine (Baltimore). 2015 May;94(17):e777. doi: 10.1097/MD.0000000000000777.

23.

Minimal change nephrotic syndrome associated with non-Hodgkin lymphoid disorders: a retrospective study of 18 cases.

Kofman T, Zhang SY, Copie-Bergman C, Moktefi A, Raimbourg Q, Francois H, Karras A, Plaisier E, Painchart B, Favre G, Bertrand D, Gyan E, Souid M, Roos-Weil D, Desvaux D, Grimbert P, Haioun C, Lang P, Sahali D, Audard V.

Medicine (Baltimore). 2014 Nov;93(24):350-8. doi: 10.1097/MD.0000000000000206. Erratum in: Medicine (Baltimore). 2014 Nov;93(24):414.

24.

Acute metabolic acidosis in a GLUT2-deficient patient with Fanconi-Bickel syndrome: new pathophysiology insights.

Mihout F, Devuyst O, Bensman A, Brocheriou I, Ridel C, Wagner CA, Mohebbi N, Boffa JJ, Plaisier E, Ronco P.

Nephrol Dial Transplant. 2014 Sep;29 Suppl 4:iv113-6. doi: 10.1093/ndt/gfu018.

25.

Improving mutation screening in familial hematuric nephropathies through next generation sequencing.

Morinière V, Dahan K, Hilbert P, Lison M, Lebbah S, Topa A, Bole-Feysot C, Pruvost S, Nitschke P, Plaisier E, Knebelmann B, Macher MA, Noel LH, Gubler MC, Antignac C, Heidet L.

J Am Soc Nephrol. 2014 Dec;25(12):2740-51. doi: 10.1681/ASN.2013080912. Epub 2014 May 22.

26.

Pemetrexed-induced acute kidney injury leading to chronic kidney disease.

Chauvet S, Courbebaisse M, Ronco P, Plaisier E.

Clin Nephrol. 2014 Dec;82(6):402-6. doi: 10.5414/CN107921.

PMID:
24424085
27.

Predictors of early relapse in patients with non-infectious mixed cryoglobulinemia vasculitis: results from the French nationwide CryoVas survey.

Terrier B, Marie I, Launay D, Lacraz A, Belenotti P, de Saint-Martin L, Quemeneur T, Huart A, Bonnet F, Le Guenno G, Kahn JE, Hinschberger O, Rullier P, Diot E, Lazaro E, Bridoux F, Zénone T, Carrat F, Hermine O, Léger JM, Mariette X, Senet P, Plaisier E, Cacoub P.

Autoimmun Rev. 2014 Jun;13(6):630-4. doi: 10.1016/j.autrev.2013.11.006. Epub 2014 Jan 10. Review.

PMID:
24418300
28.

Tubulointerstitial nephropathies in HIV-infected patients over the past 15 years: a clinico-pathological study.

Zaidan M, Lescure FX, Brochériou I, Dettwiler S, Guiard-Schmid JB, Pacanowski J, Rondeau E, Pialoux G, Girard PM, Ronco P, Plaisier E.

Clin J Am Soc Nephrol. 2013 Jun;8(6):930-8. doi: 10.2215/CJN.10051012. Epub 2013 Feb 21.

29.

The spectrum of type I cryoglobulinemia vasculitis: new insights based on 64 cases.

Terrier B, Karras A, Kahn JE, Le Guenno G, Marie I, Benarous L, Lacraz A, Diot E, Hermine O, de Saint-Martin L, Cathébras P, Leblond V, Modiano P, Léger JM, Mariette X, Senet P, Plaisier E, Saadoun D, Cacoub P.

Medicine (Baltimore). 2013 Mar;92(2):61-8. doi: 10.1097/MD.0b013e318288925c.

30.

Rituximab is an efficient and safe treatment in adults with steroid-dependent minimal change disease.

Munyentwali H, Bouachi K, Audard V, Remy P, Lang P, Mojaat R, Deschênes G, Ronco PM, Plaisier EM, Dahan KY.

Kidney Int. 2013 Mar;83(3):511-6. doi: 10.1038/ki.2012.444. Epub 2013 Jan 16.

31.

Hepatitis C virus infection, mixed cryoglobulinemia, and kidney disease.

Fabrizi F, Plaisier E, Saadoun D, Martin P, Messa P, Cacoub P.

Am J Kidney Dis. 2013 Apr;61(4):623-37. doi: 10.1053/j.ajkd.2012.08.040. Epub 2012 Oct 25. Review.

PMID:
23102733
32.

Prognostic factors of survival in patients with non-infectious mixed cryoglobulinaemia vasculitis: data from 242 cases included in the CryoVas survey.

Terrier B, Carrat F, Krastinova E, Marie I, Launay D, Lacraz A, Belenotti P, de Saint Martin L, Quemeneur T, Huart A, Bonnet F, Le Guenno G, Kahn JE, Hinschberger O, Rullier P, Hummel A, Diot E, Pagnoux C, Lzaro E, Bridoux F, Zenone T, Hermine O, Leger JM, Mariette X, Senet P, Plaisier E, Cacoub P.

Ann Rheum Dis. 2013 Mar;72(3):374-80. doi: 10.1136/annrheumdis-2012-201405. Epub 2012 May 14.

PMID:
22586172
33.

Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey.

Terrier B, Krastinova E, Marie I, Launay D, Lacraz A, Belenotti P, de Saint-Martin L, Quemeneur T, Huart A, Bonnet F, Le Guenno G, Kahn JE, Hinschberger O, Rullier P, Diot E, Lazaro E, Bridoux F, Zénone T, Carrat F, Hermine O, Léger JM, Mariette X, Senet P, Plaisier E, Cacoub P.

Blood. 2012 Jun 21;119(25):5996-6004. doi: 10.1182/blood-2011-12-396028. Epub 2012 Apr 3.

PMID:
22474249
34.

HIV-associated kidney glomerular diseases: changes with time and HAART.

Lescure FX, Flateau C, Pacanowski J, Brocheriou I, Rondeau E, Girard PM, Ronco P, Pialoux G, Plaisier E.

Nephrol Dial Transplant. 2012 Jun;27(6):2349-55. doi: 10.1093/ndt/gfr676. Epub 2012 Jan 16.

PMID:
22248510
35.

[Kidney and HIV infection].

Plaisier E, Lescure FX, Ronco P.

Presse Med. 2012 Mar;41(3 Pt 1):267-75. doi: 10.1016/j.lpm.2011.11.011. Epub 2012 Jan 14. Review. French. Erratum in: Presse Med. 2012 Sep;41(9 Pt 1):889-90.

PMID:
22245017
36.

INF2 mutations in Charcot-Marie-Tooth disease with glomerulopathy.

Boyer O, Nevo F, Plaisier E, Funalot B, Gribouval O, Benoit G, Huynh Cong E, Arrondel C, Tête MJ, Montjean R, Richard L, Karras A, Pouteil-Noble C, Balafrej L, Bonnardeaux A, Canaud G, Charasse C, Dantal J, Deschenes G, Deteix P, Dubourg O, Petiot P, Pouthier D, Leguern E, Guiochon-Mantel A, Broutin I, Gubler MC, Saunier S, Ronco P, Vallat JM, Alonso MA, Antignac C, Mollet G.

N Engl J Med. 2011 Dec 22;365(25):2377-88. doi: 10.1056/NEJMoa1109122.

37.

Anti TNF-α in refractory Takayasu's arteritis: cases series and review of the literature.

Comarmond C, Plaisier E, Dahan K, Mirault T, Emmerich J, Amoura Z, Cacoub P, Saadoun D.

Autoimmun Rev. 2012 Jul;11(9):678-84. doi: 10.1016/j.autrev.2011.11.025. Epub 2011 Dec 4. Review.

PMID:
22155781
38.

Patterns of noncryoglobulinemic glomerulonephritis with monoclonal Ig deposits: correlation with IgG subclass and response to rituximab.

Guiard E, Karras A, Plaisier E, Duong Van Huyen JP, Fakhouri F, Rougier JP, Noel LH, Callard P, Delahousse M, Ronco P.

Clin J Am Soc Nephrol. 2011 Jul;6(7):1609-16. doi: 10.2215/CJN.10611110. Epub 2011 Jun 23.

39.

Monoclonal immunoglobulin light and heavy chain deposition diseases: molecular models of common renal diseases.

Ronco P, Plaisier E, Aucouturier P.

Contrib Nephrol. 2011;169:221-231. doi: 10.1159/000314778. Epub 2011 Jan 20.

PMID:
21252522
40.

Rituximab treatment for membranous nephropathy: a French clinical and serological retrospective study of 28 patients.

Michel PA, Dahan K, Ancel PY, Plaisier E, Mojaat R, De Seigneux S, Daugas E, Matignon M, Mesnard L, Karras A, François H, Pardon A, Caudwell V, Debiec H, Ronco P.

Nephron Extra. 2011 Jan;1(1):251-61. doi: 10.1159/000333068. Epub 2011 Dec 24.

41.

Ig-related renal disease in lymphoplasmacytic disorders: an update.

Ronco P, Plaisier E, Aucouturier P.

Semin Nephrol. 2010 Nov;30(6):557-69. doi: 10.1016/j.semnephrol.2010.09.004. Review.

PMID:
21146121
42.

Novel COL4A1 mutations associated with HANAC syndrome: a role for the triple helical CB3[IV] domain.

Plaisier E, Chen Z, Gekeler F, Benhassine S, Dahan K, Marro B, Alamowitch S, Paques M, Ronco P.

Am J Med Genet A. 2010 Oct;152A(10):2550-5. doi: 10.1002/ajmg.a.33659.

PMID:
20818663
43.

More on clinical renal genetics.

Grünfeld JP, Hwu W, Chien Y, Lee N, Chiang S, Dobrovolny R, Huang A, Yeh H, Chao M, Lin S, Kitagawa T, Desnick R, Hsu L, Van Keimpema L, Nevens F, Vanslembrouck R, Van Oijen G, Hoffmann A, Dekker H, De Man R, Drenth J, Alamovitch S, Plaisier E, Favrole P, Prost C, Chen Z, Van Agrmael T, Marro B, Ronco P, Zivna M, Hulkova H, Matignon M, Hodanova K, Vylet'al P, Kalbacova M, Baresova V, Sikora J, Blazkova H, Zivny J, Ivanek R, Stranecky V, Sovova J, Claes K, Lerut E, Fryns J, Hart P, Hart T, Adams J, Pawtowski A, Clemessy M, Gasc J, Gubler M, Antignac C, Elleder M, Kapp K, Grimbert P, Bleyer A, Kmoch S, Brown E, Schlöndorff J, Becker Dj, Tsukaguchi H, Uschinski A, Higgs H, Henderson J, Pollak M.

Clin J Am Soc Nephrol. 2010 Apr;5(4):563-7. doi: 10.2215/CJN.01720210. Epub 2010 Mar 25. No abstract available.

44.

Cerebrovascular disease related to COL4A1 mutations in HANAC syndrome.

Alamowitch S, Plaisier E, Favrole P, Prost C, Chen Z, Van Agtmael T, Marro B, Ronco P.

Neurology. 2009 Dec 1;73(22):1873-82. doi: 10.1212/WNL.0b013e3181c3fd12.

45.

Clinical and morphologic spectrum of renal involvement in patients with mixed cryoglobulinemia without evidence of hepatitis C virus infection.

Matignon M, Cacoub P, Colombat M, Saadoun D, Brocheriou I, Mougenot B, Roudot-Thoraval F, Vanhille P, Moranne O, Hachulla E, Hatron PY, Fermand JP, Fakhouri F, Ronco P, Plaisier E, Grimbert P.

Medicine (Baltimore). 2009 Nov;88(6):341-8. doi: 10.1097/MD.0b013e3181c1750f.

46.

Efficacy and tolerability of rituximab with or without PEGylated interferon alfa-2b plus ribavirin in severe hepatitis C virus-related vasculitis: a long-term followup study of thirty-two patients.

Terrier B, Saadoun D, Sène D, Sellam J, Pérard L, Coppéré B, Karras A, Blanc F, Buchler M, Plaisier E, Ghillani P, Rosenzwajg M, Cacoub P.

Arthritis Rheum. 2009 Aug;60(8):2531-40. doi: 10.1002/art.24703.

47.
48.

[HANAC syndrome (hereditary angiopathy with nephropathy, aneurysms and muscle cramps) and mutations of the collagen 4A1 gene: a new basement membrane hereditary pathology with multisystemic expression].

Plaisier E, Ronco P.

Nephrol Ther. 2008 Dec;4(7):632-4. doi: 10.1016/j.nephro.2008.03.013. Epub 2008 Sep 24. French. No abstract available.

PMID:
18818132
49.

COL4A1 mutations and hereditary angiopathy, nephropathy, aneurysms, and muscle cramps.

Plaisier E, Gribouval O, Alamowitch S, Mougenot B, Prost C, Verpont MC, Marro B, Desmettre T, Cohen SY, Roullet E, Dracon M, Fardeau M, Van Agtmael T, Kerjaschki D, Antignac C, Ronco P.

N Engl J Med. 2007 Dec 27;357(26):2687-95.

50.

D-Penicillamine-induced ANCA-associated crescentic glomerulonephritis in Wilson disease.

Bienaimé F, Clerbaux G, Plaisier E, Mougenot B, Ronco P, Rougier JP.

Am J Kidney Dis. 2007 Nov;50(5):821-5.

PMID:
17954295

Supplemental Content

Loading ...
Support Center